Code
01D03021
Duration
01 October 2021 → 31 October 2022
Funding
Regional and community funding: Special Research Fund
Promotor
Fellow
Research disciplines
-
Medical and health sciences
- Applied immunology
- Biopharmaceuticals
- Pharmaceutical technology
-
Engineering and technology
- Nanomaterials
Keywords
immunotherapy
T cells
cancer
nanotechnology
Project description
The goal of this project is to investigate a strategy to target CD8+ T cells in vivo for subsequent cellspecific
delivery of nanoparticle-formulated therapeutics. Via this technology, we aim to modulate T cells in vivo in the blood and in the tumor microenvironment.